'Walk-away' tools planned from Sigma, Caliper
Sigma-Aldrich and Caliper Life Sciences have teamed up to develop and co-market a series of automated systems for a wide variety of applications in genomics, proteomics, and drug discovery.
Archives for August 16, 2004
Sales up, profits down at Bachem
Fine chemicals maker Bachem has reported higher sales in the first half of the year, but profits were slightly weaker as unfavourable exchange rates took their toll.
Teva snaps up Italian generics player
Israeli generics and active pharmaceutical ingredients (API) company Teva Pharmaceutical Industries announced yet another acquisition earlier today, this time for Pfizer's Italian generic pharmaceutical marketing company Dorom.
2D gel electrophoresis market heading for boom?
Two-dimensional (2D) gel electrophoresis can be time-consuming and labour intensive, but its value to proteomics research means that the market for these products will more than double by 2010.
Chiral Quest launches first kilo-scale product
Catalyst company Chiral Quest has launched a new product, C3-TunePhos, designed for use in the synthesis of a range of drugs, including the cholesterol-lowering statin class.
BioProgress expands film-making capacity
UK-based BioProgress, the manufacturer of 'dissolve in the mouth' films, has bought two soluble film casting lines allowing it to boost its production capacity to meet growing demand for the novel delivery format.
Enzyme blockers could be new psoriasis treatment
Scientists in the UK and Germany have discovered that drugs that inhibit enzymes known as metalloproteinases have the hallmarks of a new treatment for the common skin diseases psoriasis.